EMBRYONAL RHABDOMYOSARCOMA
Clinical trials for EMBRYONAL RHABDOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new EMBRYONAL RHABDOMYOSARCOMA trials appear
Sign up with your email to follow new studies for EMBRYONAL RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise against aggressive childhood cancer
Disease control OngoingThis study tests whether adding a drug called vinorelbine to standard chemotherapy can better control high-risk rhabdomyosarcoma, a rare and aggressive muscle cancer in children and young adults. About 118 participants will receive either the standard treatment or the new combina…
Matched conditions: EMBRYONAL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 17, 2026 04:25 UTC
-
Can adding temsirolimus boost chemo for kids and young adults with muscle cancer?
Disease control OngoingThis study tests whether adding the drug temsirolimus to standard chemotherapy helps people with intermediate-risk rhabdomyosarcoma (a type of muscle cancer) live longer without the cancer growing or coming back. About 325 participants up to age 40 are randomly assigned to receiv…
Matched conditions: EMBRYONAL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC
-
Gene hunt in kids with rare cancer aims to unlock prognosis clues
Knowledge-focused OngoingThis study collects saliva or cheek cell samples from 900 children with a rare muscle cancer called rhabdomyosarcoma, along with samples from their parents. Researchers look for new or inherited gene changes that might affect how the disease behaves. The goal is to learn more abo…
Matched conditions: EMBRYONAL RHABDOMYOSARCOMA
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:10 UTC